Therefore, we used established T3A-A3 cell model to investigate the effects of 30 small-molecule compounds (majority of which we have shown to have inhibitory effects on hepatocellular carcinoma cell lines) on LCSCs activity in our laboratory, and selected PTL as a candidate for further investigation (Fig. S1B). Here, PNLIP is linked to hepatocellular carcinoma.